Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| amacrine cell | 5 studies | 58% ± 22% | |
| retina horizontal cell | 5 studies | 60% ± 20% | |
| Mueller cell | 5 studies | 57% ± 28% | |
| ON-bipolar cell | 4 studies | 53% ± 23% | |
| retinal ganglion cell | 4 studies | 76% ± 21% | |
| retinal bipolar neuron | 3 studies | 53% ± 18% | |
| OFF-bipolar cell | 3 studies | 51% ± 29% | |
| GABAergic amacrine cell | 3 studies | 47% ± 14% | |
| glycinergic amacrine cell | 3 studies | 39% ± 16% | |
| rod bipolar cell | 3 studies | 48% ± 14% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 6 studies | 36% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 6298.15 | 258 / 258 | 95% | 179.73 | 218 / 230 |
| brain | 98% | 152.96 | 2592 / 2642 | 79% | 3.00 | 557 / 705 |
| ovary | 100% | 609.77 | 180 / 180 | 59% | 2.38 | 254 / 430 |
| prostate | 85% | 74.73 | 208 / 245 | 41% | 0.70 | 207 / 502 |
| kidney | 65% | 29.61 | 58 / 89 | 55% | 8.41 | 496 / 901 |
| uterus | 98% | 151.24 | 166 / 170 | 20% | 1.00 | 93 / 459 |
| thymus | 59% | 29.37 | 386 / 653 | 38% | 0.62 | 230 / 605 |
| blood vessel | 79% | 113.74 | 1054 / 1335 | 0% | 0 | 0 / 0 |
| breast | 63% | 50.42 | 287 / 459 | 14% | 0.48 | 162 / 1118 |
| heart | 73% | 56.90 | 628 / 861 | 0% | 0 | 0 / 0 |
| bladder | 62% | 40.48 | 13 / 21 | 8% | 0.48 | 39 / 504 |
| esophagus | 56% | 53.50 | 813 / 1445 | 2% | 0.06 | 4 / 183 |
| intestine | 46% | 22.74 | 445 / 966 | 3% | 0.07 | 17 / 527 |
| lung | 39% | 21.74 | 227 / 578 | 8% | 0.38 | 93 / 1155 |
| adipose | 43% | 164.98 | 514 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 34% | 16.08 | 82 / 241 | 0% | 0 | 0 / 0 |
| skin | 33% | 44.31 | 592 / 1809 | 1% | 0.25 | 3 / 472 |
| stomach | 15% | 6.38 | 54 / 359 | 5% | 0.19 | 15 / 286 |
| muscle | 18% | 7.59 | 145 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 15% | 1.44 | 12 / 80 |
| pancreas | 2% | 0.51 | 5 / 328 | 8% | 0.39 | 15 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.08 | 1 / 29 |
| liver | 1% | 0.40 | 2 / 226 | 1% | 0.06 | 5 / 406 |
| peripheral blood | 1% | 0.68 | 13 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008089 | Biological process | anterograde axonal transport |
| GO_0097211 | Biological process | cellular response to gonadotropin-releasing hormone |
| GO_0071383 | Biological process | cellular response to steroid hormone stimulus |
| GO_0021987 | Biological process | cerebral cortex development |
| GO_0010821 | Biological process | regulation of mitochondrion organization |
| GO_0006626 | Biological process | protein targeting to mitochondrion |
| GO_0061564 | Biological process | axon development |
| GO_0019896 | Biological process | axonal transport of mitochondrion |
| GO_2000171 | Biological process | negative regulation of dendrite development |
| GO_0008090 | Biological process | retrograde axonal transport |
| GO_0071456 | Biological process | cellular response to hypoxia |
| GO_0005741 | Cellular component | mitochondrial outer membrane |
| GO_1904115 | Cellular component | axon cytoplasm |
| GO_0005743 | Cellular component | mitochondrial inner membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MGARP |
| Protein name | Protein MGARP (Corneal endothelium-specific protein 1) (CESP-1) (Hypoxia up-regulated mitochondrial movement regulator protein) (Mitochondria-localized glutamic acid-rich protein) (Ovary-specific acidic protein) |
| Synonyms | C4orf49 OSAP HUMMR GS3582 CESP1 |
| Description | FUNCTION: Plays a role in the trafficking of mitochondria along microtubules. Regulates the kinesin-mediated axonal transport of mitochondria to nerve terminals along microtubules during hypoxia. Participates in the translocation of TRAK2/GRIF1 from the cytoplasm to the mitochondrion. Also plays a role in steroidogenesis through maintenance of mitochondrial abundance and morphology (By similarity). Plays an inhibitory role during neocortex development by regulating mitochondrial morphology, distribution and motility in neocortical neurons (By similarity). . |
| Accessions | Q8TDB4 ENST00000398955.2 |
